Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Gliclazide MR	6
Overall Study	STARTED	Sitagliptin	6
Overall Study	STARTED	Pioglitazone	6
Overall Study	STARTED	Metformin	11
Overall Study	COMPLETED	Gliclazide MR	6
Overall Study	COMPLETED	Sitagliptin	6
Overall Study	COMPLETED	Pioglitazone	6
Overall Study	COMPLETED	Metformin	11
Overall Study	NOT COMPLETED	Gliclazide MR	0
Overall Study	NOT COMPLETED	Sitagliptin	0
Overall Study	NOT COMPLETED	Pioglitazone	0
Overall Study	NOT COMPLETED	Metformin	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00780715/flow